000 | 01510 a2200433 4500 | ||
---|---|---|---|
005 | 20250517151216.0 | ||
264 | 0 | _c20170608 | |
008 | 201706s 0 0 eng d | ||
022 | _a1862-3514 | ||
024 | 7 |
_a10.1007/s11657-017-0336-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIshiguro, Shigeo | |
245 | 0 | 0 |
_aThe clinical benefits of denosumab for prophylaxis of steroid-induced osteoporosis in patients with pulmonary disease. _h[electronic resource] |
260 |
_bArchives of osteoporosis _cDec 2017 |
||
300 |
_a44 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aDenosumab _xadministration & dosage |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLumbar Vertebrae _xdrug effects |
650 | 0 | 4 |
_aLung Diseases _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
650 | 0 | 4 | _aProspective Studies |
700 | 1 | _aIto, Kentaro | |
700 | 1 | _aNakagawa, Shigenori | |
700 | 1 | _aHataji, Osamu | |
700 | 1 | _aSudo, Akihiro | |
773 | 0 |
_tArchives of osteoporosis _gvol. 12 _gno. 1 _gp. 44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11657-017-0336-1 _zAvailable from publisher's website |
999 |
_c27096055 _d27096055 |